Osloc 40 Injection
Marketer
Auromentis Pharmaceuticals
Salt Composition
Pantoprazole (40mg)
Overview Osloc 40 Injection
Gastric acid production is suppressed by the intravenous medication, AcidRem 40 Injection. This treatment addresses various gastrointestinal disorders stemming from excess stomach acid, including acid reflux, peptic ulcers, and Zollinger-Ellison syndrome. It offers symptom relief and facilitates healing. AcidRem 40 Injection also prevents stress ulcers in critically ill patients and is pre-administered before anesthesia to mitigate aspiration risks. Classified as a proton pump inhibitor (PPI), it's administered intravenously by a medical professional only when deemed more appropriate than oral administration. Dosage is individualized based on your health status and response. Your physician will determine the treatment duration; however, consistent adherence is crucial, even with rapid symptom resolution. Lifestyle adjustments, such as smaller, more frequent meals and avoidance of caffeine, spicy foods, and fatty foods, enhance treatment effectiveness. Common, typically mild, adverse reactions comprise nausea, vomiting, headache, vertigo, flatulence, diarrhea, abdominal discomfort, and thrombophlebitis (vein inflammation). Persistent or bothersome side effects necessitate medical consultation. Prolonged use, especially exceeding one year and at higher doses, may elevate the risk of bone fractures. Discuss bone health preservation strategies, including calcium and vitamin D supplementation, with your doctor. AcidRem 40 Injection is contraindicated for individuals with severe hepatic impairment, those on HIV medications, those with a history of similar medication allergies, or those with osteoporosis. Pregnant or lactating individuals should seek medical advice before using this injection. Alcohol consumption should be avoided due to its acid-stimulating properties. Refrain from operating machinery or driving if experiencing dizziness or drowsiness.
Uses of Osloc 40 Injection
Managing gastroesophageal reflux, peptic ulcers, and Zollinger-Ellison syndrome.
Major Benefits of Osloc 40 Injection:
Administering this medication will be performed by your doctor or nurse; self-medication is strictly prohibited.
Common Side effects of Osloc 40 Injection:
- Diarrhea
- Flatulence
- Headache
- Joint pain
- Nausea
- Stomach pain
- Vomiting
- Dizziness
- Thrombophlebitis
How to use Osloc 40 Injection:
This medication will be administered by your physician or their designated nurse; self-medication is strictly prohibited.
How Osloc 40 Injection works:
Gastric acid production is decreased by Osloc 40 Injection, a proton pump inhibitor, thus alleviating heartburn and acid indigestion.
SAFETY ADVICE
AlcoholUNSAFE
Avoid alcohol while using Osloc 40 Injection.
PregnancyCONSULT YOUR DOCTOR
The use of Osloc 40 Injection during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the unborn child. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.
Breast feedingSAFE IF PRESCRIBED
Breastfeeding mothers can likely use Osloc 40 Injection safely. Available human data indicates minimal risk to the infant.
DrivingCONSULT YOUR DOCTOR
The effect of Osloc 40 Injection on driving ability is unknown. Refrain from driving if you develop symptoms impairing concentration or reaction time.
KidneySAFE IF PRESCRIBED
Osloc 40 Injection poses no safety concerns for individuals with renal impairment; no alteration of the Osloc 40 Injection dosage is necessary.
LiverCAUTION
For patients with severe hepatic impairment, Osloc 40 Injection requires careful administration and potential dosage modification. Physician consultation is advised.
What if you forget to take Osloc 40 Injection :
Should you forget a scheduled Osloc 40 Injection, seek medical advice.
Facts to Know About Osloc 40 Injection
| Label | Value |
|---|---|
| Pharmaceutical Category | Benzimidazole sulfoxide analog |
| Potential for Dependence | None. |
| Medication Category | Gastrointestinal tract |
| Mechanism of Action | Gastric acid secretion blockers |



